Indian government introduces UCPMP 2024 to regulate pharmaceutical marketing practices and curb unethical conduct.

The Indian government has implemented a new uniform code for pharmaceutical marketing practices, known as UCPMP 2024, to curb unethical practices in the industry. Key provisions include prohibiting gifts and travel facilities for healthcare professionals or their family members, banning supply of free samples to those not qualified to prescribe, and requiring all pharmaceutical associations to establish ethics committees to oversee marketing practices. The new code aims to ensure transparency, integrity, and accountability in the marketing of pharmaceutical products.